NCT03226704 Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing Status ENROLLING_BY_INVITATION Phase N/A
NCT03223610 Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma Status RECRUITING Phase PHASE1/PHASE2
NCT03212261 Promoting Resiliency Among Lymphoma Survivors: The 3RP-Lymphoma Status COMPLETED Phase NA
NCT03205176 AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas Status COMPLETED Phase PHASE1
NCT03200977 Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab Status COMPLETED Phase N/A
NCT03191773 A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell Malignancies Status UNKNOWN Phase PHASE1/PHASE2
NCT03189836 Study of ACTR707 in Combination With Rituximab in Subjects With Relapsed or Refractory B Cell Lymphoma Status TERMINATED Phase PHASE1
NCT03187210 Brentuximab Vedotin and BeEAM High-dose Chemotherapy in Lymphomas Status SUSPENDED Phase PHASE1/PHASE2
NCT03179930 Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03168035 Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma Status COMPLETED Phase PHASE1
NCT03167476 Comparative Study of microRNA Changes in Patients With Reactive Lymphoid Hyperplasia and Malignant Lymphoma Status UNKNOWN Phase N/A
NCT03151876 Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell Lymphoma Status UNKNOWN Phase PHASE2
NCT03144674 A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204) Status COMPLETED Phase PHASE2
NCT03144583 Pilot Study on the Infusion of ARI-0001 Cells in Patients With CD19+ Leukemia or Lymphoma Refractory to Therapy Status COMPLETED Phase PHASE1
NCT03141437 Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT03141398 Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology Group Status WITHDRAWN Phase N/A
NCT03137537 Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy. Status TERMINATED Phase PHASE2
NCT03135743 Retrospective Analysis of Lymphomas and Cancers Synchronous Occurrence in Picardy From 2007 to 2012 Status WITHDRAWN Phase N/A
NCT03130582 High-dose Etoposide Could Discriminate Patients With Refractory/Relapsed Lymphoma Benefit From APBSCT Status COMPLETED Phase N/A